Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

LB03 - Exploration of Early Signalling Events of CLL upon Exposure to Low Dose Combination of Ibrutinib and Venetoclax

    Primary Author(s)

  • PP

    Prasanta Paul, PhD in Pharmaceutical Sciences

    Post doctoral fellow
    University of Manitoba
    Winnipeg, Manitoba, Canada

    • Co-Author(s)

  • CP

    Cheryl Peltier, BSc

    Paul Albrechtsen Research Institute (CancerCare Manitoba) & Department of Internal Medicine (University of Manitoba
    Winnipeg, Manitoba, Canada

  • EM

    Eileen McMilllan Ward, MSc

    Paul Albrechtsen Research Institute (CancerCare Manitoba) & Department of Internal Medicine (University of Manitoba
    Winnipeg, Manitoba, Canada

  • MS

    Maxim Skorondinsky, MSc

    University of Manitoba
    Winnipeg, Manitoba, Canada

  • YL

    Ying Lao, MSc

    Manitoba Centre for Proteomics and Systems Biology (University of Manitoba)
    Winnipeg, Manitoba, Canada

  • VS

    Victor Spicer, BSc

    Lead Bioinformatician
    Manitoba Centre for Proteomics and Systems Biology (University of Manitoba)
    Winnipeg, Manitoba, Canada

  • SR

    Subir Roy Chowdhury, PhD

    Research Associate
    Nemours Children’s Health System
    Jacksonville, Florida, United States

  • AZ

    Athanasios Zovoilis, PhD

    Associate Professor
    University of Manitoba and CancerCareManitoba
    Winnipeg, Manitoba, Canada

  • YM

    Yale Michaels, PhD

    Assistant Professor
    University of Manitoba and Paul Albrechtsen Research Institute
    Winnipeg, Manitoba, Canada

  • RZ

    Rene Zahedi, PhD

    Professor
    University of Manitoba, Paul Albrechtsen Research Institute
    Winnipeg, Manitoba, Canada

    • Co-Author / Presenter(s)

  • VB

    Versha Banerji, MD, PhD

    Associate Professor
    University of Manitoba, Paul Albrechtsen Research Institute, CancerCareManitoba
    Winnipeg, Manitoba, Canada